| Issue Date | Title | Author(s) |
| 2015 | Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103 | Davies, J; Chen, J; Pink, R; Carter, D; Saunders, N; Sotiriadis, G; Bai, B; Pan, Y; Howlett, D; Payne, A; Randeva, H; Karteris, E |
| 2010 | Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines | Mparmpakas, D; Zachariades, E; Foster, H; Kara, A; Harvey, AJ; Goumenou, A; Karteris, E |
| 2010 | Congenital imperforate hymen with hydrocolpos and hydronephrosis associated with severe hydramnios and increase of maternal ovarian steroidogenic enzymes | Karteris, E; Foster, H; Karamouti, M; Goumenou, A |
| 2011 | Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization | Zachariades, E; Foster, H; Goumenou, A; Thomas, P; Rand-Weaver, M; Karteris, E |
| 2018 | Prognostic value of the DNA integrity index in patients with malignant lung tumors | Chudasama, DY; Aladag, Z; Felicien, MI; Hall, M; Beeson, J; Asadi, N; Gidron, Y; Karteris, E; Anikin, VB |
| 2018 | Involvement of the glutamine RF-amide peptide (QRFP) and its cognate receptor GPR103 in prostate cancer | Karteris, E; Kawan, M; Kyrou, I; Ramanjaneya, M; Williams, K; Jeyaneethi, J; Randeva, H |
| 2018 | Functional Cardiac Orexin Receptors: Role of Orexin-B/Orexin 2 Receptor in Myocardial Protection. | Karteris, E; Patel, VH; Chen, J; Kyrou, I; Mattu, H; Dimitriadis, G; Rodrigo, G; Antoniades, C; Antonopoulos, A; Tan, B; Hillhouse, E; Ng, A; Randeva, H |
| 2016 | Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro | Rogers-Broadway, KR; Chudasama, D; Pados, G; Tsolakidis, D; Goumenou, A; Hall, M; Karteris, E |
| 9-Jun-2017 | Perioperative detection of circulating tumour cells in patients with lung cancer | Chudasama, D; Burnside, N; Beeson, J; Karteris, E; Rice, A; Anikin, V |
| 31-Oct-2018 | Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry | Rogers‑Broadway, KR; Kumar, J; Sisu, C; Wander, G; Mazey, E; Jeyaneethi, J; Pados, G; Tsolakidis, D; Klonos, E; Grunt, T; Hall, M; Chatterjee, J; Karteris, E |
